PrecisionFDA is an initiative by the U.S. Food and Drug Administration (FDA) aimed at advancing the science of genomics and improving the use of next-generation sequencing (NGS) in clinical and regulatory settings. Launched in 2015, PrecisionFDA serves as a collaborative platform where researchers, regulatory professionals, and other stakeholders can share and evaluate genomic data, tools, and methods.
Articles by others on the same topic
There are currently no matching articles.